ObsEva SA to Host R&D Investor Day December 7, 2018
Geneva, Switzerland and Boston, MA – November 29, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics for serious conditions that compromise a woman’s …